The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar, scheduled for April 1, 2026, focuses on the integration of precision diagnostics and innovative therapies in the management of Renal Cell Carcinoma (RCC).

Chaired by Viktor Gruenwald, the program addresses the clinical challenges of treatment sequencing and patient selection in a rapidly evolving therapeutic landscape. Key sessions cover molecular tailoring for treatment stratification, the emergence of molecular imaging as a diagnostic and therapeutic tool, and evidence-based strategies for second-line management of metastatic RCC.

Register.